Free CME workshop series helps address the increasing public health threat of HCV among people who inject drugs

Friday, November 4, 2016 Drug News J E 4

BALTIMORE, Nov. 3, 2016 /PRNewswire/ -- Johns Hopkins University School of Medicine, one of the leading healthcare systems in the United States, and Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), have collaborated to provide a free, community-focused CME workshop series to clinicians in the mid-atlantic and Appalachia regions of the country, HCV Education Summit: Building Integrated Care Teams to Combat the Growing Epidemic.

"HCV infection has become a growing public health threat in the United States," said Mark Sulkowski, MD, Medical Director of the Viral Hepatitis Center at Johns Hopkins University School of Medicine in Baltimore, MD. "The recent development of highly effective antiviral regimens has led to a cure for most patients, making the eradication of HCV a feasible goal, but well-coordinated multidisciplinary care teams are equally necessary to achieve this objective."

The collaboration between Johns Hopkins and Med-IQ on this initiative was formed to educate local clinicians on the barriers that influence the delivery of optimal, coordinated care to patients with hepatitis C virus (HCV) infection. Workshop participants explore strategies for identifying and managing HCV and learn best practices for forming local, cohesive, strategic care teams for patients with HCV and/or at high risk of HCV acquisition, such as those who are addicted to opioid medications.

With 3 workshops scheduled in the Maryland and Pennsylvania areas, the goal is to educate as many clinicians as possible on this growing epidemic:

  • Baltimore, MD—November 19th
  • Waldorf, MD—December 12th
  • Pittsburgh, PA—December 17th

Interested clinicians can register for free by calling (toll-free) 866 858 7434, e-mailing, or completing this brief online form. For more information on workshop locations and agenda, please visit

These workshops are approved for AMA PRA Category 1 Credit™.

This activity is supported by educational grants from AbbVie and Gilead Sciences, Inc.

About Med-IQMed-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance.

To learn more about Med-IQ, visit, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.

To view the original version on PR Newswire, visit:




You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
India Multiparameter Patient Monitoring Market Out...
Star-Studded Gala for GENYOUth® Celebrates Youth E...